EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cinética de fósforo en pacientes con insuficiencia renal crónica en hemodiálisis.

Juan Manuel Duran, María Inés Gil Arredondo, Pedro Trinidad Ramos

Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante. · 2022

DOI: 10.56867/13 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Hyperphosphatemia is one of the factors associated with high mortality in patients with chronic renal failure in dialysis programs. The objective of the present study was to perform intra- and post-dialysis serum phosphorus (P) kinetics, taking into account factors such as dialysis time and extracorporeal flow (Qs). Methods: This cross-sectional study was conducted from September 2018 to January 2019. Baseline phosphate levels were analyzed at 60, 120, 180, and 240 intradialytic and 1 and 2 hours post-hemodialysis. A descriptive analysis was performed. Linear regression was performed to determine factors associated with post-hemodialysis serum P levels. Results: 56 patients were included, 48 ± 13 years old, 30 women (53%), 46 with a catheter (82%), and 27 (48%) received treatment for 240 minutes. Qs of 300 ml/min in 11%, 350 ml/min in 65%, and 400 ml/min in 26% of cases. pH 7.3 ± 0.6, Hemoglobin 9.4 ±1.6 gr/dL. Basal P, at 60, 120, 180, and 240 minutes, was 5.3, 3.5, 2.9, 2.7, and 2.6 mg/dl, respectively. The P at 60 and 120 minutes post-HD were 3.5 and 3.75 mg/dl, respectively. Factors associated with the phosphorus level at 120 min post hemodialysis were hemoglobin P=0.004, Standardized beta coefficient (CBE) 0.247 (95% CI 0.04-0219), and phosphorus removal at 240 min P=0.001, CBE=0.503, (CI95% 0.265-0.905). Conclusions: The decrease in phosphate in the study group was 50.9%, with a rebound elevation at 2 hours of 21.82%. Hemoglobin above 11 gr/dl is a factor associated with hyperphosphataemia. The intensity of phosphorus removal at 240 minutes is associated with serum phosphorus levels.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →